Cargando…

Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease

Technological solutions are increasingly seen as a way to respond to the demands of managing complex chronic conditions, especially neurodegenerative diseases such as Parkinson’s Disease. All of these new possibilities provide a variety of chances to improve the lives of affected persons and their f...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz-Luhn, Bjoern, Chandler, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225587/
https://www.ncbi.nlm.nih.gov/pubmed/35743795
http://dx.doi.org/10.3390/jpm12061011
_version_ 1784733652570079232
author Schmitz-Luhn, Bjoern
Chandler, Jennifer
author_facet Schmitz-Luhn, Bjoern
Chandler, Jennifer
author_sort Schmitz-Luhn, Bjoern
collection PubMed
description Technological solutions are increasingly seen as a way to respond to the demands of managing complex chronic conditions, especially neurodegenerative diseases such as Parkinson’s Disease. All of these new possibilities provide a variety of chances to improve the lives of affected persons and their families, friends, and caregivers. However, there are also a number of challenges that should be considered in order to safeguard the interests of affected persons. In this article, we discuss the ethical and legal considerations associated with the use of technology-assisted care in the context of neurodegenerative conditions.
format Online
Article
Text
id pubmed-9225587
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92255872022-06-24 Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease Schmitz-Luhn, Bjoern Chandler, Jennifer J Pers Med Article Technological solutions are increasingly seen as a way to respond to the demands of managing complex chronic conditions, especially neurodegenerative diseases such as Parkinson’s Disease. All of these new possibilities provide a variety of chances to improve the lives of affected persons and their families, friends, and caregivers. However, there are also a number of challenges that should be considered in order to safeguard the interests of affected persons. In this article, we discuss the ethical and legal considerations associated with the use of technology-assisted care in the context of neurodegenerative conditions. MDPI 2022-06-20 /pmc/articles/PMC9225587/ /pubmed/35743795 http://dx.doi.org/10.3390/jpm12061011 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schmitz-Luhn, Bjoern
Chandler, Jennifer
Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease
title Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease
title_full Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease
title_fullStr Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease
title_full_unstemmed Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease
title_short Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease
title_sort ethical and legal aspects of technology-assisted care in neurodegenerative disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225587/
https://www.ncbi.nlm.nih.gov/pubmed/35743795
http://dx.doi.org/10.3390/jpm12061011
work_keys_str_mv AT schmitzluhnbjoern ethicalandlegalaspectsoftechnologyassistedcareinneurodegenerativedisease
AT chandlerjennifer ethicalandlegalaspectsoftechnologyassistedcareinneurodegenerativedisease
AT ethicalandlegalaspectsoftechnologyassistedcareinneurodegenerativedisease